See Who's Attending - Ophthalmology Innovation Summit (OIS)
See Who's Attending - Ophthalmology Innovation Summit (OIS)
See Who's Attending - Ophthalmology Innovation Summit (OIS)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
65. Jack Elands, CEO -‐ Amakem Therapeutics 66. Fred Ellis, V.P. Sales, Eye Care -‐ Alcon Laboratories 67. David Epstein, MD, Professor & Chairman -‐ Duke Eye Center 68. Joyce Erony, Managing Director -‐ Signet Healthcare Partners 69. Dominik Escher, MD, Head of ESBATech -‐ ESBATech, a Novartis company LLC 70. David Evans, MD, CEO -‐ Ceatus Media Group LLC 71. Edward Eveleth, Partner -‐ Z Lens LLC 72. Malvina Eydelman, MD, Director, Division of Ophthalmic, & Ear, Nose & Throat Devices -‐ Food and Drug Administration 73. Peter Falzon, General Manager, USA and Asia -‐ Quantel Medical 74. Jennifer Fazio, Associate Director, Commercial Partnering -‐ GENENTECH 75. Vladimir Feingold, MD, CTO -‐ Presbia 76. Sandy Feldman, MD, Medical Directory -‐ ClearView Eye & Laser Medical Center 77. John Ferro, Director, New Business Initiatives -‐ HOYA Surgical Optics 78. Donald Fishbein, Vice President & General Manager -‐ Valeant Ophthalmics a division of Valeant Pharmaceuticals North America LLC 79. Scott Foote, Founder, SVP Managing Director Life Sciences -‐ Square 1 Bank 80. Mark Forchette, President & CEO -‐ OptiMedica 81. Colin Francou, Corporate Business Development Manager -‐ Laboratories Thea 82. K. Bailey Freund, MD -‐ Vitreous Retina Macula Consultants of New York 83. Matthew Frinzi, Founder & Chief Business Officer -‐ PowerVision, Inc. 84. Tom Frinzi, President & CEO -‐ WaveTec 85. Irgit Fuhlendorff, Head of Biopharma Technical Service -‐ Novozymes Biopharma DK A/S 86. Nicholas Galakatos, Managing Director -‐ Clarus Ventures, LLC 87. James Garvey, Chairman & Managing Partner -‐ SV Life Sciences Advisers LLC 88. Joel Gaslin, Vice President of Sales & Marketing -‐ Sightpath Medical 89. Charline Gauthier, Executive-‐in-‐Residence -‐ InterWest Partners 90. Paul Gavaris, MD, Managing Member -‐ LacriPen 91. Aniz Girach, MD, Head of Clinical <strong>Ophthalmology</strong> -‐ ThromboGenics, NV 92. Marc Gleeson, VP, U.S. Eye Care Glaucoma & External Disease Marketing -‐ Allergan, Inc. 93. Morton Goldberg, MD, Joseph Green Professor of <strong>Ophthalmology</strong> -‐ Wilmer Eye Institute, Johns Hopkins University and Hospital 94. Michael Goldstein, MD, Head of Clinical Research -‐ Eleven Biotherapeutics 95. Frederic Gomez, Business Development Advisor, <strong>Ophthalmology</strong> -‐ MC2 Biotek Group 96. Mark Gordon, Divisional Vice President, Regulatory Affairs -‐ Abbott Medical Optics Inc. 97. Jim Graham, Principal -‐ Sante Ventures 98. David Guyer, MD, Chief Executive Officer -‐ Ophthotech 99. Larry Haimovitch, Reporter -‐ Medical Device Daily
100. Julia Haller, MD, Ophthalmologist-‐in-‐Chief -‐ Wills Eye Institute 101. Dave Harmon, President -‐ Market Scope, LLC 102. Eve Higginbotham, MD, Co-‐Founder, Director-‐ROI Squared/Prof. of <strong>Ophthalmology</strong>-‐Emory University -‐ ROI Squared, LLC 103. John Higuchi, CEO -‐ Aciont Inc. 104. AnnMarie Hipsley, MD, Founder & President -‐ Ace Vision Group 105. Peter Hnik, MD, Chief Medical Officer -‐ iCo Therapeutics Inc. 106. Allen Ho, MD -‐ Mid Atlantic Retina 107. Jeffrey Hoffman, Managing Dir. & Head West Coast Healthcare Investment Banking -‐ JP Morgan 108. Jack Holladay, MD, Clinical Professor of <strong>Ophthalmology</strong> -‐ Baylor College of Medicine 109. Edward Holland, MD, Director Cornea Service, Cincinnati Eye Institute, Prof. of <strong>Ophthalmology</strong>, Univ. of Cincinnati -‐ Cincinnati Eye Institute 110. Dunbar Hoskins, MD, EVP Emeritus -‐ American Academy of <strong>Ophthalmology</strong> 111. David Huang, MD, Weeks Professor of <strong>Ophthalmology</strong> -‐ Casey Eye Institute-‐Oregon Health & Science University 112. Mark Humayun, MD, Physician/Clinician -‐ University of Southern California 113. Nouhad Husseini, Director, Business Development -‐ Regeneron Pharmaceuticals, Inc. 114. Jim Jogerst, Global Head, BD&L -‐ Alcon Laboratories 115. Patrick Johnson, Director, Business Development -‐ Allergan, Inc. 116. Lorraine Jones, Senior Director New Products -‐ Shire 117. Mike Judy, Chief Commercial Officer -‐ AcuFocus 118. Minyoung Jung, Team Manager -‐ Taejoon Pharm 119. Steve Jwanouskos, Director, Regulatory Affairs -‐ OptiMedica Corporation 120. Malik Kahook, MD, Associate Professor -‐ University of Colorado 121. John Kanellopoulos, MD, Medical Director, Clinical Prof. of <strong>Ophthalmology</strong>, NYU Med School -‐ LaserVision 122. Jennifer Kang-‐Mieler, Associate Professor of Biomedical Engineering -‐ Illinois Institute of Technology 123. David Karcher, Executive Director -‐ American Society of Cataract & Refractive Surgery 124. Michael Kaschke, MD, President & CEO -‐ Carl Zeiss AG 125. Todd Katz, MD, Ophthalmologist, Retinal Specialist -‐ Bayer HealthCare Pharmaceuticals 126. Paul Kaufman, MD, Professor & Chair -‐ UW School of Medicine & Public Health 127. Edwin Keates, MD, President -‐ Polytherapeutics Inc. 128. Terry Kim, MD, Professor of <strong>Ophthalmology</strong> -‐ Duke University Eye Center 129. Rich Kirkner, Executive Editor -‐ PentaVision, LLC 130. Gilbert Kliman, MD, Managing Director -‐ InterWest Partners 131. Gregg Kokame, MD, Medical Director -‐ Hawaii Macula and Retina Institute 132. Casey Kopczynski, Chief Scientific Officer -‐ Aerie Pharmaceuticals, Inc. 133. Susan Koppy, Corporate & Business Development Executive -‐ iCo Therapeutics Inc. 134. Colman Kraff, MD, Principal Owner -‐ Kraff Eye Institute 135. Henk-‐Andre Kroon, MD, Head of Global Clinical Development -‐ Santen, Inc.
136. Ryo Kubota, MD, Chairman, President & CEO -‐ Acucela Inc. 137. Phillips Kirk Labor, MD, President -‐ Eye Consultants of Texas 138. Stephen Lane, MD, Medical Director -‐ Associated Eye Care 139. Jesper Lange, President -‐ MC2 Biotek Group 140. Rod Lashley, Executive Vice President -‐ STATKING Clinical Services 141. Michael Lawless, MD, Medical Director -‐ Vision Eye Institute 142. Eliot Lazar, MD, President -‐ elCON Medical 143. Jun Hee Lee, General Manager -‐ Taejoon Pharma 144. Joon Youb Lee, MD, Chief Executive Officer -‐ Taejoon Pharm 145. Karen Leshem, CEO -‐ ViSci Ltd 146. Bryan Levy, Chief Medical Officer -‐ Aerie Pharmaceuticals, Inc. 147. Richard Lewis, MD -‐ Surgical Eye Specialists 148. Robert Lieberman, Associate Director -‐ Bayer HealthCare Pharmaceuticals 149. Barry Linder, MD, Chief Medical Officer -‐ Clarity Medical Systems, Inc. 150. Dick Lindstrom, MD, Founder & <strong>Attending</strong> Surgeon -‐ Minnesota Eye Consultants 151. William Link, Managing Director -‐ Versant Ventures 152. Sanjay Logani, MD, President -‐ Doctorsoft Corp 153. Zohar Loshitzer, MD, Chief Executive Officer -‐ Presbia 154. Karin Ludwig, MD, VP, Clinical Development -‐ Acucela Inc. 155. Angela Macfarlane, President & CEO -‐ ForSight Labs, LLC 156. Scott MacRae, MD, -‐ University of Rochester 157. Naresh Mandava, MD, Professor & Chair -‐ University of Colorado 158. Sabri Markabi, MD, Chief Medical Officer & Sr. VP, R&D -‐ Alcon Laboratories, Inc. 159. Beth Marsh, Principal -‐ BAM <strong>Ophthalmology</strong> Consultants, LLC 160. Daniel Martin, Chairman -‐ Cole Eye Institute -‐ The Cleveland Clinic 161. Edward Mathers, Partner -‐ New Enterprise Associates, Inc. 162. Catherine Mazzacco, VP Global Commercial Operations -‐ Abbott Medical Optics 163. James Mazzo, Operating Partner – Versant Ventures 164. James McCulley, MD, Chairman, Department of <strong>Ophthalmology</strong> -‐ Univ Tx Southwestern Med Ctr/Med School 165. Charles McDermott, VP Business Development -‐ Kala Pharmaceuticals Inc. 166. Peter McDonnell, Director & William Holland Wilmer -‐ The Wilmer Ophthalmological Institute 167. Paul McLean, President & CEO -‐ ClarVista Medical 168. Stephen McLeod, MD, Professor & Chairman -‐ University of California, San Francisco 169. Edward Meier, MD, Director of Clinical Research -‐ Apex Eye 170. Pascal Merchiers, Portfolio Management -‐ ThromboGenics, NV 171. Scott Meyer, Director, Strategic Business Development -‐ Carl Zeiss Meditec 172. William Mieler, MD, Professor & Vice-‐Chairman -‐ University of Illinois at Chicago 173. David Milne, Managing Partner -‐ SV Life Sciences 174. Yari Mitchell, Director of Global Training and PR -‐ AcuFocus, Inc.
175. Keiko Mitsunobu, Executive Director, Business Development -‐ Acucela Inc. 176. Chris Moore, CEO -‐ Integrity Digital Solutions 177. Cristina Muccioli, MD, Professor of <strong>Ophthalmology</strong> -‐ Federal University of Sao Paulo 178. Keith Mullowney, MD, President & CEO -‐ Clarity Medical Systems, Inc. 179. David Muth, President & CEO -‐ Croma Pharmaceutical Inc. 180. Dan Myers, Co-‐Founder, President & CEO -‐ Alimera Sciences 181. Suzana Nahum Zilberberg, CEO -‐ BioLight 182. Joel Naor, MD, Head of/Executive Director, Global Medical Affairs -‐ Santen, Inc. 183. Schalon Newton, Vice President -‐ SMBD -‐ Santen Inc. 184. Jon Norris, Managing Director -‐ SVB Capital 185. Gary Novack, President -‐ PharmaLogic Development, Inc. 186. Kan Ohtsuki, Director & General Manager R&D Div. -‐ Nidek Co., Ltd 187. Timothy Olsen, MD, F. Phinizy Calhoun Sr. Professor & Chairman -‐ Emory University 188. Randall Olson, CEO -‐ University of Utah Moran Eye Center 189. Paul Onderick, Intellectual Property Attorney, Partner -‐ Patterson Thuente IP 190. Quinton Oswald, Business Unit Lead -‐ SHIRE 191. Sandro Palumbo, Vice President Marketing -‐ Ziemer Ophthalmic Systems AG 192. David Parke II, MD, Executive Director -‐ American Academy of <strong>Ophthalmology</strong> 193. Ketan Patel, Principal -‐ Fidelity Biosciences 194. Samir Patel, MD, President & CEO -‐ Ophthotech Corp. 195. Vincent Patella, VP Professional Affairs -‐ Carl Zeiss Meditec, Inc. 196. Bruce Peacock, CBO -‐ Ophthotech 197. David Pearson, President & Global Head of Corporate Development -‐ ThromboGenics, Inc. 198. Rudolf Peschke, MD, CEO -‐ Peschke Meditrade GmbH 199. Guillaume Pfefer, President & CEO -‐ Kala Pharmaceuticals, Inc. 200. Hans-‐Peter Pfleger, VP, Commercial Operations & Strategic Marketing -‐ Acucela Inc. 201. Wouter Piepers, Global Head of Corporate Communications -‐ ThromboGenics, NV 202. Richard Powers, EVP -‐ VisionCare Ophthalmic Technologies 203. Arnold Prywes, MD, Medical Doctor -‐ Glaucoma Consultants of Long Island 204. David Pyott, Chairman of the Board, President &CEO -‐ Allergan, Inc. 205. Jane Rady, Divisional VP, Business Development -‐ Abbott Medical Optics 206. Ramgopal Rao, CEO -‐ LensGen,Inc. 207. Hayette Rebika, MD, Ophthalmologist -‐ CHU Gabriel Montpied 208. Sherman Reeves, Partner -‐ Minnesota Eye Consultants 209. Carl Regillo, MD, Professor of <strong>Ophthalmology</strong> -‐ Mid Atlantic Retina-‐Wills Eye Institute 210. Philip Risser, Global Development Team Leader -‐ Genentech, Inc. 211. Calvin Roberts, MD, EVP, Chief Medical Officer -‐ Bausch + Lomb, Inc. 212. Neil Robinson, MD, CEO -‐ Ocean Eye Institute 213. Michiel Rombach, MD, CEO -‐ AkkoLens International BV 214. Philip Rosenfeld, MD, Professor of <strong>Ophthalmology</strong> -‐ Bascom Palmer Eye Institute
215. Michael Ross, MD, President & Chief Operating Officer -‐ Euclid Systems Corp. 216. Cameron Rouns, Divisional Vice President, Global Marketing -‐ Abbott Medical Optics 217. Tera Roy, Specialty Director -‐ <strong>Ophthalmology</strong> and ENT -‐ NextGen Healthcare 218. Anne Rubin, Vice President, Marketing -‐ ForSight Vision5, Inc. 219. Roman Rubio, MD, Group Medical Director -‐ Genentech 220. Tom Samuelson, MD, Founding Partner & <strong>Attending</strong> Surgeon -‐ Minnesota Eye Consultants 221. Brent Saunders, CEO -‐ Bausch + Lomb, Inc. 222. Baldo Scassellati Sforzolini, VP Global Drug Development -‐ Bausch & Lomb 223. Eberhard Schmidt, CEO -‐ SensoMotoric Instruments GmbH 224. Susan Schneider, MD, Vice President, Retina -‐ Acucela Inc. 225. Brian Schwam, MD, Vice President, Chief Medical Officer -‐ Johnson & Johnson Vision Care, Inc. 226. Donald Schwartz, CEO -‐ EyeSonix 227. Daniel Schwartz, MD -‐ UCSF 228. Rolf Schwind, CEO -‐ SCHWIND eye-‐tech-‐solutions GmbH & Co.KG 229. William Shea, Vice President, Research & Development -‐ Clarity Medical Systems, Inc. 230. Arthur Shedden, MD, Director, Global Medical Affairs -‐ Johnson & Johnson Vision Care, Inc. 231. Amir Shojaei, Sr. Director R&D Product Strategy -‐ Shire 232. Paul Sieving, MD, Director -‐ National Eye Institute 233. Rona Silkiss, Chief, Div. of Ophthalmic Plastic, Reconstructive & Orbital Surgery -‐ California Pacific Medical Center 234. Murthy Simhambhatla, President -‐ Abbott Medical Optics 235. Nicholas Simon, Managing Director -‐ Clarus Ventures 236. Lawrence Singerman, MD, -‐ Retina Associates of Cleveland, Inc. 237. Shweta Singh, Senior Manager, Commercial Partnering -‐ GENENTECH 238. Tamil Singh, Marketing/Sales -‐ Doctorsoft Corp. 239. Kuldev Singh, MD, Professor -‐ Stanford University 240. Arun Singh, MD, Editor, British Journal of <strong>Ophthalmology</strong> -‐ Cleveland Clinic <strong>Innovation</strong>s 241. Steve Slade, MD, Surgeon -‐ Slade & Baker Vision Center 242. Kerry Solomon, MD, Director -‐ Carolina Eyecare Research Institute 243. Alfred Sommer, MD 244. Paul Soye, MD, VP-‐R&D, Global Franchise Head-‐Cataract Surgery -‐ Alcon Laboratories, Inc. 245. Joseph Spadafora, MD, Physician -‐ Community Eye Center 246. Bruce Spivey, MD, President -‐ International Council of <strong>Ophthalmology</strong> 247. Roger Steinert, MD, Professor & Chair -‐ University of California, Irvine 248. Ellen Strahlman, MD, Chief Medical Officer -‐ Becton, Dickinson and Company 249. Doyle Stulting, MD, Director -‐ Woolfson Eye Institute 250. Timothy Sullivan, President & CEO -‐ Mystic Pharmaceuticals, Inc. 251. Glenn Sussman, Vice President, Research & Development -‐ ClarVista Medical 252. Greg Tackoor, Director Business Development -‐ Johnson & Johnson Vision Care, Inc. 253. Jonathan Talamo, MD, Ophthalmologist -‐ Talamo Hatch Laser Eye Consultants
Change language